Pharmacogenetic Testing of Cytochrome P450 Drug Metabolizing Enzymes in a Case Series of Patients with Prader-Willi Syndrome

Pharmacogenetic Testing of Cytochrome P450 Drug Metabolizing Enzymes in a Case Series of Patients with Prader-Willi Syndrome

Prader-Willi syndrome (PWS) is associated with co-morbid psychiatric symptoms (disruptive behavior, anxiety, mood disorders, and psychosis) often requiring psychotropic medications. In this clinical case series of 35 patients with PWS, pharmacogenetic testing was obtained to determine allele frequen...

Full description

Bibliographic Details
Main Authors: Janice Forster, Jessica Duis, Merlin G. Butler
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Genes
Subjects:
pharmacogenetic testing
cytochrome P450 enzymes
Prader-Willi syndrome
drug interactions
medication management
Online Access:https://www.mdpi.com/2073-4425/12/2/152

Internet

https://www.mdpi.com/2073-4425/12/2/152

Similar Items